Literature DB >> 25954687

A study on the prescribing pattern of drugs for acne in a tertiary care teaching hospital in odisha.

Nibedita Patro1, Monalisa Jena2, Maitreyee Panda1, Mrutyunjay Dash3.   

Abstract

BACKGROUND: Acne vulgaris is a common disease of the skin affecting the socially vulnerable young age group. There are multitudes of treatment options available but till now no studies have been reported to demonstrate the current prescribing pattern of drugs in acne vulgaris. AIM: To study the prescribing pattern of drugs in acne in a tertiary care teaching hospital in Odisha, India.
MATERIALS AND METHODS: The study was an observational study conducted for a period of one year on patients more than 10 yeras age and having acne attending the Skin & VD OPD. Drug induced acne and acneiform eruptions were excluded.
RESULTS: A total of 1210 prescriptions of acne were analysed. The male to female ratio was 1:1.29. Most patients presented with grade 2 (60%) acne followed by grade 3 (20.99%). Out of prescribed drugs, 47.44% were oral and 52.56% were topical formulations. Oral isotretinoin (68.10%) was the most frequently prescribed drug among oral formulations. Doxycycline (54.18%) was the most preferable oral antibiotic. The average number of drugs per prescription was 3.003. Polypharmacy was preferred over monotherapy.
CONCLUSION: In the management of acne, judicious and early intervention with oral isotretinoin improves the overall treatment outcome, the fact which has increased its use in acne patients.

Entities:  

Keywords:  Acne vulgaris; Doxycycline; Isotretinoin; Polypharmacy

Year:  2015        PMID: 25954687      PMCID: PMC4413137          DOI: 10.7860/JCDR/2015/11634.5675

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

1.  Acne epidemiology and pathophysiology.

Authors:  Sheila F Friedlander; Lawrence F Eichenfield; Joseph F Fowler; Richard G Fried; Moise L Levy; Guy F Webster
Journal:  Semin Cutan Med Surg       Date:  2010-06

Review 2.  Guidelines of care for acne vulgaris management.

Authors:  John S Strauss; Daniel P Krowchuk; James J Leyden; Anne W Lucky; Alan R Shalita; Elaine C Siegfried; Diane M Thiboutot; Abby S Van Voorhees; Karl A Beutner; Carol K Sieck; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2007-02-05       Impact factor: 11.527

3.  Post-adolescent acne: a review of clinical features.

Authors:  V Goulden; S M Clark; W J Cunliffe
Journal:  Br J Dermatol       Date:  1997-01       Impact factor: 9.302

Review 4.  Persistent acne in women : implications for the patient and for therapy.

Authors:  Christina Williams; Alison M Layton
Journal:  Am J Clin Dermatol       Date:  2006       Impact factor: 7.403

5.  Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel.

Authors:  Susan Bershad; Giselle Kranjac Singer; Janice E Parente; Mei-Heng Tan; Daniel W Sherer; Andrea N Persaud; Mark Lebwohl
Journal:  Arch Dermatol       Date:  2002-04

6.  The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.

Authors:  J Imperato-McGinley; T Gautier; L Q Cai; B Yee; J Epstein; P Pochi
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

7.  Profile of acne vulgaris--a hospital-based study from South India.

Authors:  Balaji Adityan; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 May-Jun       Impact factor: 2.545

Review 8.  Diagnosis and treatment of acne.

Authors:  Steven Feldman; Rachel E Careccia; Kelly L Barham; John Hancox
Journal:  Am Fam Physician       Date:  2004-05-01       Impact factor: 3.292

9.  Red light phototherapy alone is effective for acne vulgaris: randomized, single-blinded clinical trial.

Authors:  Jung Im Na; Dae Hun Suh
Journal:  Dermatol Surg       Date:  2007-10       Impact factor: 3.398

10.  A clinico-epidemiological study of adult acne: is it different from adolescent acne?

Authors:  Niti Khunger; Chandan Kumar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 May-Jun       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.